Alma Medical Private Limited, the Indian subsidiary of the Israeli manufacturer that’s among the global innovators in lasers for medical, light-based, radiofrequency, and ultrasound solutions in the aesthetic, surgical and beauty (spa) markets, is expanding further into Asia, where it already has a strong presence, especially in India, China, Korea and Japan, apart from Australia. The Indian medical lasers market, including in aesthetics, which was valued at ₹715.72 million in FY2023, is expected to increase to ₹1,835.
08 million in FY2031, with a CAGR of 12.49% for the forecast period, according to industry estimates. Alma’s laser platforms, which have been selling in India since 2007, are seen as strong brands.
The company credits itself with having changed millions of lives worldwide in over 25 years with its clinically proven applications. “Access to aesthetics is showcased in Alma’s R&D process as we are investing in innovative approaches to enable treatment for a diverse range of skin types, even the most complicated ones, to enable aesthetics for all,” Alon Tzionit, president of Alma India Pvt. Ltd.
, told The Hindu . With laser treatment now more accessible than ever before, whereas cost was hitherto a factor that limited access, the Indian market for laser treatments is expanding alongside growth in GDP. Alma India, too, has been able to expand at speed, and reach Tier 2 cities.
Alma’s Soprano Titanium is regarded as a ‘gold standard’ the B2B, B2C a.
